InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Korbel Gregory Alan, Executive. Officer active across 1 company, notably Aprea Therapeutics, Inc.. Aggregated, 10 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €23k. History available since 25 August 2021. The latest transaction was disclosed on 28 July 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Korbel Gregory Alan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
24,300 shares0Common StockSEC:0001104659-22-084767:0
8,390 shares@ US$0.8055.8% of flowCommon StockSEC:0001104659-22-069001:0
16,000 shares0Common StockSEC:0001104659-22-033392:0
1,326 shares@ US$1.741.9% of flowCommon StockSEC:0001104659-22-028761:0
27,500 shares@ US$0.9220.6% of flowCommon StockSEC:0001104659-21-146396:0
27,500 shares@ US$0.9220.2% of flowCommon StockSEC:0001104659-21-133785:0
27,500 shares@ US$0.9220.2% of flowCommon StockSEC:0001104659-21-123185:0
5,460 shares@ US$4.9821.4% of flowCommon StockSEC:0001104659-21-118363:0
1,724 shares@ US$4.596.2% of flowCommon StockSEC:0001104659-21-115547:0
1,149 shares@ US$3.983.6% of flowCommon StockSEC:0001104659-21-110599:0
10 of 10 declarations
About Korbel Gregory Alan
Korbel Gregory Alan is Dirigeant at Aprea Therapeutics, Inc. (XNAS), where he serves as SVP, Chief Operating Officer. Across 10 filings, the sampled filings cover the period from 2021-08-27 to 2022-08-01, with 0 EUR in buys and 23180 EUR in sells, and the most frequent transaction nature is Retenue fiscale.
